Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2019 Results Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Alex Dasalla - Head, IR Joe Ciaffoni - CEO Paul Brannelly - CFO Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Jaffray Greg Fraser - SunTrust Tian Sun - Needham & Company David Steinberg - Jefferies Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald Kevin Kedra - G. Research Operator Good day, and welcome to the Q2 2019 Col ...